hydroxymatairesinol and Uterine-Neoplasms

hydroxymatairesinol has been researched along with Uterine-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for hydroxymatairesinol and Uterine-Neoplasms

ArticleYear
Chemopreventive effects of hydroxymatairesinol on uterine carcinogenesis in Donryu rats.
    Experimental biology and medicine (Maywood, N.J.), 2004, Volume: 229, Issue:5

    Hydroxymatairesinol (HMR), obtained from the heartwood of spruce (Picea abies), has been demonstrated to exert chemo-preventive effects on the development of mammary tumors in rats. To examine the influence of HMR on uterine carcinogenesis, adult Donryu rats were initiated with a single intrauterine treatment of N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG) at 11 weeks of age and fed thereafter 0, 200, or 600 ppm HMR mixed in the soy-containing diet until 15 months of age. Incidences of uterine adenocarcinoma in both 200 and 600 ppm HMR-dosed groups were significantly reduced to 11% and 15%, respectively, less than 50% of 0 ppm, at the end of the experiment (P < 0.05). A delay in the start of persistent estrus by HMR was observed at 8 months of age compared with controls given carcinogen alone. From urinalysis, HMR was metabolized mainly to enterolactone and hydroxyenterolactone. These findings suggest that HMR or its metabolites exert chemo-preventive effects in the rat ENNG-uterine carcinogenesis model.

    Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Carcinogens; Dose-Response Relationship, Drug; Estrus; Feeding Behavior; Female; Lignans; Methylnitronitrosoguanidine; Rats; Uterine Neoplasms

2004